forecast
CGM Competition Is Not the Key Risk
Competition is not the main threat to Dexcom because manufacturing difficulty has created a graveyard of failed CGM attempts, so the market should remain a stable duopoly for the foreseeable future.
forecastpending
Speaker
AnealEvidence Quote
“competition is not one of them. This is a focus from Wall Street, but from studying the history of CGMs, there has been a graveyard of CGMs in development”
Created: 11/20/2026, 5:18:27 AM
Your notes
Loading notes...